- +672.0% price growth over the last year
- High gross margin of 99.5%
- Lower volatility than the market (beta 0.18)
Evaluation of Ovid Therapeutics Inc stock downgraded after the last trading session
(Updated on Jun 03, 2026)
The Ovid Therapeutics Inc stock price fell by -0.417% on the last day (Wednesday, 3rd Jun 2026) from $2.40 to $2.39. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 6.47% from a day low at $2.32 to a day high of $2.47. The price has been going up and down for this period, and there has been a -0.42% loss for the last 2 weeks. Volume has increased on the last day by 788 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $5.26 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.30 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 23.16% during the next 3 months and, with a 90% probability hold a price between $2.83 and $4.07 at the end of this 3-month period.
OVID Signals & Forecast
There are few to no technical positive signals at the moment. The Ovid Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.53 and $2.67. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 14, 2026, and so far it has fallen -19.26%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Ovid Therapeutics Inc stock
Ovid Therapeutics Inc finds support from accumulated volume at $2.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.150 between high and low, or 6.47%. For the last week, the stock has had daily average volatility of 8.58%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (OVID) For The Upcoming Trading Day Of Thursday 4th
For the upcoming trading day on Thursday, 4th we expect Ovid Therapeutics Inc to open at $2.39, and during the day (based on 14 day Average True Range), to move between $2.30 and $2.48, which gives a possible trading interval of +/-$0.173 (+/-7.53%) up or down from last closing price. If Ovid Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 7.53% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.30 (3.77%) than the resistance at $2.56 (7.11%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Ovid Therapeutics Inc stock A Buy?
The Ovid Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe Ovid Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score:
-5.450
Strong Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 4, 2026 - $2.39 ( 0.139%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
OVID Performance
Trading levels for OVID
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.54 | 6.42% |
| R2 | 2.49 | 4.02% |
| R1 | 2.45 | 2.54% |
| Price | 2.39 | |
| S1 | 2.34 | -2.26% |
| S2 | 2.30 | -3.74% |
| S3 | 2.24 | -6.14% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.79 | 16.74% |
| R2 | 2.62 | 9.62% |
| R1 | 2.56 | 7.11% |
| Price | 2.39 | |
| S1 | 2.30 | -3.77% |
| S2 | 2.14 | -10.46% |
| S3 | 1.85 | -22.59% |
FAQ
Click here for our free guide on how to buy Ovid Therapeutics Inc Stock.
Buy OVID